Pharmaceuticals

Plasma Protein Therapeutics Market 2026 growing with chronic disease treatments

March 24, 2026March 24, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Expansion Is Predicted For The Plasma Protein Therapeutics Market Between 2026 And 2030?

The plasma protein therapeutics market size has demonstrated significant expansion in recent years. It is projected to increase from $34.68 billion in 2025 to $37.09 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.9%. The historical growth in this market stems from factors such as the increasing prevalence of primary immunodeficiency disorder, a rising demand for immunoglobulin therapies, the limited plasma donation infrastructure, advancements in protein purification technologies, and regulatory approvals for plasma-derived therapies.

The plasma protein therapeutics market is anticipated to demonstrate robust expansion over the next few years. It is projected to achieve a valuation of $48.98 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.2%. This anticipated growth can be attributed to several factors, including the increased availability of recombinant albumin and coagulation factors, the proliferation of subcutaneous administration methods, rising healthcare expenditure in emerging economies, advancements in precision medicine technologies, and a rise in public-private collaborations for plasma collection. Prominent trends expected during this forecast period include the development of personalized plasma protein therapies, the expansion of recombinant protein production capabilities, an increase in the adoption of subcutaneous administration, growing public awareness of rare blood disorders, and enhancements in supply chain and cold chain logistics.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9213&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Plasma Protein Therapeutics Market?

The increasing prevalence of autoimmune disorders is projected to fuel the expansion of the plasma protein therapeutics market moving forward. An autoimmune disorder is a condition that develops when the body’s immune system mistakenly attacks and eradicates healthy body cells. Therapeutic plasma exchange is employed to manage autoimmune diseases, which arise when the body incorrectly identifies a part of itself as alien and subsequently produces proteins, known as autoantibodies, that target the misidentified body part. For instance, in May 2023, a study carried out by the University of Glasgow, a UK-based public university, involving 22 million people, indicated that autoimmune disorders impact approximately 10% of the UK’s population, surpassing earlier estimates from 2022. Therefore, the rising incidence of autoimmune disorders is driving the growth of the plasma protein therapeutics market in the future.

Which Market Segments Are Examined In The Plasma Protein Therapeutics Market Study?

The plasma protein therapeutics market covered in this report is segmented –

1) By Product: Immunoglobulin, Albumin, Coagulation Factor, C1-esterase Inhibitors, Other Products

2) By Route Of Administration: Intravenous, Subcutaneous

3) By Applications: Primary Immunodeficiency Disorder (PID), Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency, Hereditary Angioedema, Other Applications

Subsegments:

1) By Immunoglobulin: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)

2) By Albumin: Human Serum Albumin, Recombinant Albumin

3) By Coagulation Factor: Factor VIII, Factor IX, Prothrombin Complex Concentrates

4) By C1-Esterase Inhibitors: Human C1-Esterase Inhibitors, Recombinant C1-Esterase Inhibitors

5) By Other Products: Fibrinogen, Alpha-1 Antitrypsin, Clotting Factor Concentrates

Which Trends Are Influencing The Plasma Protein Therapeutics Market?

Major companies operating in the plasma protein therapeutics market are concentrating on developing innovative solutions, such as lyophilized plasma formulations, to meet the increasing demand for portable, stable, and rapid-use blood products in emergency and pre-hospital care settings. Lyophilized plasma products are freeze-dried formulations that provide a longer shelf life, easier storage, and quicker reconstitution compared to traditional frozen plasma, making them highly appropriate for trauma, emergency medicine, and field environments. For instance, in October 2023, Octapharma AG, a Switzerland-based pharmaceutical company, secured approval from European medical authorities for the lyophilized version of its octaplasLG product. This advanced formulation facilitates convenient pre-hospital transfusion, offering rapid availability, simplified handling, and enhanced stability for critical care situations. The product supports effective management of trauma and bleeding emergencies, demonstrating Octapharma’s commitment to improving patient care through innovative plasma-based therapies.

Who Are The Primary Competitors In The Plasma Protein Therapeutics Market?

Major companies operating in the plasma protein therapeutics market are CSL Behring LLC, Grifols SA, China Biologic Products Holdings Inc., Takeda Pharmaceutical Company Limited, Baxter International Inc., Kedrion SpA, LFB SA, Emergent BioSolutions Inc., Reliance Life Sciences Private Limited, ADMA Biologics Inc., Prothya Biosolutions BV, Bio Products Laboratory Ltd., Biotest AG, Taibang Biological Group Co Ltd, Octapharma Plasma Inc., Green Cross Corporation, China National Biotec Group Company Limited, Kamada Ltd., Shire PLC, Octapharma AG

Read the full plasma protein therapeutics market report here:

https://www.thebusinessresearchcompany.com/report/plasma-protein-therapeutics-global-market-report

What Are The Leading Geographic Regions In The Plasma Protein Therapeutics Market?

North America was the largest region in the plasma protein therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma protein therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Plasma Protein Therapeutics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9213&type=smp

Browse Through More Reports Similar to the Global Plasma Protein Therapeutics Market 2026, By The Business Research Company

Plasma Protein Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/plasma-protein-therapeutics-global-market-report

Therapeutic Plasma Exchange Market Report 2026

https://www.thebusinessresearchcompany.com/report/therapeutic-plasma-exchange-global-market-report

Peptide Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795